Sleep Comfortably. Sleep Peacefully. Sleep Restfully.

CPAP, Oxygen Equipment & Supplies at Low Prices

1-866-923-2727

We accept

Resmed S9 Enhanced AutoSet

S9 Logo S9 AUtoSet

ResMed is a world leading manufacturer of CPAP therapy devices and accessories incorporating the finest technology available. The S9 Enhanced AutoSet incorporates special technology that is capable of making the difference between OSA (Obstructive Sleep Apnea) and CSA (Central Sleep Apnea). The device intelligently differentiates between the two types of apneas and delivers optimum therapy to the mask.

Patients can now enjoy the most comfortable and efficient therapy at the lowest pressures. Thus, therapy becomes even more like natural breathing, and patients can become quickly compliant with therapy using the S9 Enhanced AutoSet algorithm.

The S9 series with Enhanced AutoSet algorithm adjust CPAP pressure dynamically, to deliver pressure that is most comfortable for the patient to breathe in. Enhanced AutoSet technology monitors the patient’s breathing cycle on a breath by breath basis, and is capable of delivering the most efficient therapy at the lowest possible therapeutic pressures.

The S9 Enhanced AutoSet algorithm intelligently detects the difference between an open and a closed airway and thus it delivers the most custom tailored CPAP therapy. In order to identify whether the patient’s airways are open or closed during an apnea episode, the device uses FOT- Forced Oscillation Technique.

Through this intelligent technology, the device is capable of adding small pressure oscillations to the pressure that is currently set on the device. Then, the CSA algorithm will analyze data from the flow and pressure that results, in order to detect whether the patient’s airway is closed or open. This is how CSA detection works with S9 Enhanced AutoSet algorithms, and this is what makes the S9 AutoSet and S9 Elite CPAP devices so different from other machines within the same range.

OSA vs. CSA Important Guide

Obstructive Sleep Apnea (OSA) occurs when the airway is limited/ blocked while sleeping. Patients diagnosed with OSA can encounter even hundreds of such apnea episodes during one night. When the patient cannot breathe because of an obstructed airway, the oxygen levels within the blood will drop and the blood pressure increases - exposing the patient to real health dangers. However, when the right CPAP sleep therapy device is used, apnea episodes will not occur anymore, since the airways are maintained open and therapeutic quality oxygen is constantly delivered.

Central Sleep Apnea (CSA) occurs in cases when the brain of the patient will give up sending the right signal to the muscles that are in full control of breathing. During CSA episodes, the patient can stop breathing for even up to 30 seconds, time during which the blood oxygen saturation drops and this exposes the patient to certain health hazards.

There are basically two different breathing disorders strongly linked to Central Sleep Apnea, and these are Periodic Breathing and Cheyne-Stokes respiration. During a CSA episode, even though the airways are open, airflow (breathing process) is not present. Clinicians highly recommend using the most intelligent and efficient sleep therapy devices for patients struggling with OSA or CSA.

The intelligent S9 Enhanced AutoSet algorithm is fully capable of making the difference between OSA and CSA and instantly deliver the required type of pressure and oxygen therapy.  

S9 Series AutoSet

Learn More About the New S9

Free Shipping - Minimum spend $99

Sleep Restfully, Inc.
3100 Weslayan Street, Suite 373
Houston, TX 77027
(866) 923-2727
(281) 840-4504
Fax:(800) 540-5078
(281) 501-7969

Facebook Twitter Google Plus Email

ResMed AirSense 19 AutoSet
Respironics Amara View Full Face CPAP Mask
Z1 Auto Travel CPAP
C-100 CPAP Battery
Silent Night Mask Liners
DreamStation CPAP Machine
CPAP Mask without a prescription
Philips Respironics SimplyGo Mini Portable Oxygen Concentrator
Copyright © 2006 - 2016 Sleep Restfully, Inc | All Rights Reserved | © ResMed 2016. Used with permission.